# BCG for Therapeutic Use Phase Ⅲ Clinical Trial

> **NCT06747455** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.** · enrollment: 439 (actual)

## Conditions studied

- BCG

## Interventions

- **DRUG:** BCG for Therapeutic Use
- **DRUG:** BCG for Therapeutic Use ( BI SAI JI )

## Key facts

- **NCT ID:** NCT06747455
- **Lead sponsor:** Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 439 (ACTUAL)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06747455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06747455, "BCG for Therapeutic Use Phase Ⅲ Clinical Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06747455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*